ABBOTT LABORATORIES — Director's Dealing 2006

Feb 9, 2006

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-12-01

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-12-01	Common shares without par value	G	369	—	Disposed	61096	Direct
2006-02-07	Common shares without par value	M	24807	$33.2314	Acquired	85903	Direct
2006-02-07	Common shares without par value	F	21102	$42.42	Disposed	64801	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2006-02-07	Option (right to buy)	$33.2314	M	24807	Disposed	2013-02-13	Common shares (24807)	Direct
2006-02-07	Option (right to buy)	$42.42	A	21102	Acquired	2013-02-13	Common shares (21102)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	14758	Indirect
Common shares without par value	20000	Indirect
Common shares without par value	853	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 7, 2006.

F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in a transaction exempt from Section 16 under 16(a)-11.

F4: Reporting person disclaims beneficial ownership of all securities held by his son.

F5: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3